PRESTIGE BIOPHARMA 프레스티지바이오파마 Prestigebiopharma

Innovation for Life

Developing Innovative drugs, Biosimilars, Platforms, and Diagnostic technologies to improve lives.

Advancing Antibody Science

Advancing antibody drugs and biosimilars to address unmet medical needs.

Creating Value for a Healthier Life

Improving patient access through cost-effective, high-quality biosimilars.

PRESTIGE BIOPHARMA

PRESTIGE BIOPHARMA IDC

PRESTIGE BIOLOGICS

7

Beyond technological discovery, expanding access to care for patients around the world

Innovative Drug

Development of First-in-Class therapeutics for unmet diseases

Biosimilar

Prominent Biosimilars pipelines for accelerating market access

Platform Technology

A drug delivery platform that enhances treatment convenience

Diagnostics

Diagnostics for Pancreatic cancer by detecting PAUF

Prestige News

Total 81

Number	Thumbnail	Title	Author	Date	Votes	Views
81		Prestige Biopharma Unveils Subcutaneous Injection Platform... Seeks Technology Licensing Opportunities 김** \| 2026.10.26 \| Votes 0 \| Views 197	김**	2026.10.26	0	197
80		Prestige Biopharma to Present Phase 1 Clinical Data for Pancreatic Cancer Drug Candidate PBP1510 at ESMO 2026 김** \| 2026.10.23 \| Votes 0 \| Views 393	김**	2026.10.23	0	393
79		Prestige Biopharma Participates in CPHI Milan 2026 to Expand Global Partnerships 김** \| 2026.10.07 \| Votes 0 \| Views 863	김**	2026.10.07	0	863
78		Prestige Biopharma IDC's Taeheung Kang, Director of Drug Development Division: 'Additional Pipelines Ready… Accelerating Resear 김** \| 2026.10.01 \| Votes 0 \| Views 898	김**	2026.10.01	0	898
77		Prestige Biopharma Appoints Neil O’Connor as Board Director, Strengthening Expertise in CMC and Quality Management 김** \| 2026.09.30 \| Votes 0 \| Views 770	김**	2026.09.30	0	770
76		Prestige Biopharma Receives Brazilian Marketing Authorization for Herceptin Biosimilar Tuznue 김** \| 2026.09.28 \| Votes 0 \| Views 1064	김**	2026.09.28	0	1064
75		Prestige Biopharma’s Tuznue Receives Marketing Authorization in Trinidad and Tobago 김** \| 2026.09.18 \| Votes 0 \| Views 1185	김**	2026.09.18	0	1185
74		Prestige Biopharma IDC Obtains ISO 14001 and ISO 45001 Certifications 김** \| 2026.09.17 \| Votes 0 \| Views 960	김**	2026.09.17	0	960
73		Prestige Biopharma Successfully Concludes ‘Prestige Symposium’ on Aging 김** \| 2026.09.09 \| Votes 0 \| Views 1504	김**	2026.09.09	0	1504
72		Prestige Biopharma IDC CEO Ko Sang-seok Purchases Company Shares on the Open Market 김** \| 2026.09.03 \| Votes 0 \| Views 1916	김**	2026.09.03	0	1916

1
2
3
4
5
6
7
8
9
»
Last

Read Prestige news >>